Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

HHS Secretary Robert F. Kennedy Jr. was on The Tucker Carlson Show last week. It got me to thinking: What's next in RFK Jr.'s ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

ORLANDO, FLORIDA / ACCESS Newswire / July 3, 2025 / RedChip Companies will air interviews with Fathom Holdings, Inc.

A growing number of physicians shift focus to consulting and digital health roles for better work-life balance and financial ...

The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple disease targets.

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

Traditional medical tests often require clinical samples to be sent off-site for analysis in a time-intensive and expensive ...

Scientists have gained an atomic-level view of plant cells, getting to know the metacaspase 9 enzyme in the process.

Bruce Leuchter, CEO, Neurvati, discusses the vital role of public participation in healthcare policy, highlighting how ...

Explore innovative clinical trial design with digital twins, enhancing predictions while reducing costs and efforts in ...